The Patent Finder

Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same

Nexus Pharmaceuticals, LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 7 of these applications claim priority to application 62/849,125, filed May 16, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 11,090,278Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
In force
 · High confidence
Nexus Pharmaceuticals, LLCIn force
High confidence
US 11,241,400Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
In force
 · High confidence
Nexus Pharmaceuticals, LLCIn force
High confidence
US 11,426,369Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
In force
 · Medium confidence
Nexus Pharmaceuticals, LLCIn force
Medium confidence
US 11,464,752Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
In force
 · High confidence
Nexus Pharmaceuticals, LLCIn force
High confidence
US 11,478,436Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
In force
 · Medium confidence
Nexus Pharmaceuticals, LLCIn force
Medium confidence
US 11,571,398Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
In force
 · Medium confidence
Nexus Pharmaceuticals, LLCIn force
Medium confidence
US 12,797,345Compositions Comprising Ephedrine or an Ephedrine Salt and Methods of Making and Using Same
In force
 · Medium confidence
Nexus Pharmaceuticals, LLCIn force
Medium confidence
7 of 7 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited